Mouse Complement Receptors Type 1 (CR1; CD35) and Type 2 (CR2; CD21): Expression on Normal B Cell Subpopulations and Decreased Levels during the Development of Autoimmunity in MRL/lpr Mice 1

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1557-1569

  Takahashi, Kazuko ^b   Kozono, Yuko ^a   Waldschmidt, Thomas J ^b   Berthiaume, Dawn ^a   Quigg, Richard J ^c   Baron, Anna ^a   Holers, V Michael ^a,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR;

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW; BONE MARROW CELL; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOGLOBULIN GENE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PERITONEAL CAVITY; SPECIES DIFFERENCE; SPLEEN; T LYMPHOCYTE SUBPOPULATION; THYMUS; WESTERN BLOTTING;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; BLOTTING, WESTERN; BONE MARROW; BONE MARROW CELLS; IMMUNOGLOBULIN SWITCH REGION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED MRL LPR; PERITONEAL CAVITY; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; SPECIES SPECIFICITY; SPLEEN; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 0031202759     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Heyman, B. 1994. The role of complement receptors in the regulation of the immune response. In New Aspects of Complement Structure and Function. A. Erdei, ed. CRC Press, Austin, p. 59.
2. Luxembourg, A. T., and N. R. Cooper. 1994. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153:4448.
3. Dempsey, P., M. Allison, S. Akkaraju, C. Goodnow, and D. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
4. Kozono, Y., R. C. Duke, M. S. Schleicher, and V. M. Holers. 1995. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur. J. Immunol. 25:1011.
5. Bonnefoy, J. Y., S. Henchoz, D. Hardie, M. J. Holder, and J. Gordon. 1993. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23:969.
6. Ross, G. D. 1992. Complement receptor type I. Curr. Top. Microbiol. Immunol. 178:31.
7. r membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 81:881.
8. Fingeroth, J. D., J. J. Weis, T. F. Tedder, J. L. Strominger, P. A. Biro, and D. T. Fearon. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81:4510.
9. Nemerow, G. R., R. Wolfert, M. E. McNaughton, and N. R. Cooper. 1985. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J. Virol. 55:347.
10. Aubry, J. P., S. Pochon, P. Graber, K. U. Jansen, and J. Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505.
11. Aubry, J.-P., S. Pochon, J.-F. Gauchat, A. Nueda-Marin, V. M. Holers, P. Graber, C. Siegfried, and J.-Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 5806.
12. Delcayre, A. X., F. Salas, S. Mathur, K. Kovats, M. Lotz, and W. Lernhardt. 1991. Epstein-Barr virus/complement C3d receptor is an interferon α receptor. EMBO J. 10:919.
13. Molina, H., T. Kinoshita, K. Inoue, J.-C. Carel, and V. M. Holers. 1990. A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145: 2974.
14. Kurtz, C. B., E. O'Toole, S. M. Christensen, and J. H. Weis. 1990. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144:3581.
15. Tedder, T. F., L. T. Clement, and M. D. Cooper. 1984. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133:678.
16. Kinoshita, T., J. Takeda, K. Hong, H. Kozono, H. Sakai, and K. Inoue. 1988. Monoclonal antibodies to mouse complement receptor type 1 (CR1): their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol. 140:3066.
17. Kinoshita, T., G. Thyphronitis, G. C. Tsokos, F. D. Finkelman, K. Hong, H. Sakai, and K. Inoue. 1990. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2:651.
18. Reynes, M., J. P. Aubert, J. H. M. Cohen, J. Audouin, V. Tricottet, J. Diebold, and M. D. Kazatchkine. 1985. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J. Immunol. 135:2687.
19. Kinoshita, T., T. Fujita, and R. Tsunoda. 1991. Expression of complement receptors CR1 and CR2 on murine follicular dendritic cells and B lymphocytes. In Dendritic Cells in Lymphoid Tissues. Y. Imai, J. G. Tew, and E. C. M. Hoefsmit, eds. Elsevier Science Publishers, Amsterdam, p. 271.
20. Holers, V. M., T. Kinoshita, and H. Molina. 1992. Evolution of mouse and human complement C3 binding proteins: divergence of form but conservation of function. Immunol. Today 13:231.
21. Heyman, B., E. J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665.
22. Thyphronitis, G., T. Kinoshita, K. Inoue, J. E. Schweinle, G. C. Tsokos, E. S. Metcalf, F. D. Finkelman, and J. E. Balow. 1991. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147: 224.
23. Molina, H., V. M. Holers, B. Li, Y. Fang, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, W. R. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357.
24. Ahearn, J. M., M. B. Fischer, C. Denise, G. Siegfried, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
25. Croix, A. D., M. J. Ahearn, M. A. Rosengard, S. Han, G. Kelsoe, M. Ma, and C. M. Carroll. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857.
26. Hebell, T., J. M. Ahearn, and D. T. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254:102.
27. Campana, D., G. Janossy, M. Bofill, L. K. Trejdosiewicz, D. Ma, V. Hoffbrand, D. Y. Mason, A. M. Lebacq, and H. K. Forster. 1985. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J. Immunol. 134:1524.
28. Uckun, F. M. 1990. Regulation of human B-cell ontogeny. Blood 76:1908.
29. Timens, W., A. Boes, and S. Poppema. 1989. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation. Eur. J. Immunol. 19:2163.
30. Stashenko, P., L. M. Nadler, R. Hardy, and S. F. Schlossman. 1981. Expression of cell surface markers after human B lymphocyte activation. Proc. Natl. Acad. Sci. USA 78:3848.
31. Boyd, A. W., K. C. Anderson, A. S. Freedman, D. C. Fisher, B. Slaughenhoupt, S. F. Schlossman, and L. M. Nadler. 1985. Studies of in vitro activation and differentiation of human B lymphocytes: phenolypic and functional characterization of the B cell population responding to anti-Ig antibody. J. Immunol. 134: 1516.
32. Roome, A. J., and C. L. Reading. 1987. Frequency of B-lymphocyte transformation by Epstein-Barr virus decreases with entry into the cell cycle. Immunology 60:195.
33. Tedder, T. F., D. T. Fearon, G. L. Gartland, and M. D. Cooper. 1983. Expression of C3b receptors on human B cells and myelomonocytic cells but not natural killer cells. J. Immunol. 130:1688.
34. Wilson, J. G., W. D Ratnoff, P. H. Schur, and D. T. Fearon. 1986. Decreased expression of the C3b/C4h receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. 29:739.
35. Levy, E., J. Ambrus, L. Kahl, H. Molina, K. Tung, and V. M. Holers. 1992. T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 90:235.
36. Marquart, H. V., A. Svendsen, J. M. Rasmussen, C. H. Nielsen, P. Junker, S.-E. Svehag, and R. G. Q. Leslie. 1995. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 101:60.
37. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269.
38. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
39. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
40. Nemazee, D., C. Guiet, K. Buerki, and A. Marshak-Rothstein. 1991. B lymphocytes from the autoimmune-prone mouse strain MRL/lpr manifest an intrinsic defect in tetraparental MRL/lpr:DBA/2 chimeras. J. Immunol. 147:2536.
41. Perkins, D. L., R. M. Glaser, C. A. Mahon, J. Michaelson, and A. Marshak-Rothstein. 1990. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J. Immunol. 145:549.
42. Sobel, E. S., T. Katagiri, K. Katagiri, S. C. Morris, P. L. Cohen, and R. A. Eisenberg. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173:1441.
43. Shlomchik, M. J., M. P. Madaio, D. Ni, M. Trounstein, and D. Huszar. 1994. The role of B cells in lpr/lpr induced autoimmunity. J. Exp. Med 180:1295.
44. + peripheral T cells. Cell. Immunol. 70:311.
45. Rao, M., W. T. Lee, and D. H. Conrad. 1987. Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE. J. Immunol. 138:1845.
46. Springer, T., G. Galfre, D. S. Secher, and C. Milstein. 1978. Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur. J. Immunol. 8:539.
47. Ledbetter, J. A., and L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.
48. Marshak-Rothstein, A., P. Fink, T. Gridley, D. H. Raulet, M. J. Bevan, and M. L. Getter. 1979. Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J. Immunol. 122:2491.
49. Unkeless, J. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
50. Katona, I. M., J. F. Urban, I. Scher, C. Kanellopoulos-Langevin, and F. D. Finkelman. 1983. Induction of an IgE response in mice by Nippostrongylus brasiliensis: characterization of lymphoid cells with intracytoplasmic or surface IgE. J. Immunol. 130:350.
51. Foy, T. M., and T. J. Waldschmidt. 1993. Switching capacity of Fc∈RII-positive and -negative murine B cells. Eur. J. Immunol. 23:3208.
52. Scheffe, H. 1959. The Analysis of Variance. John Wiley and Sons, New York.
53. Best, C. G., J. D. Kemp, and T. J. Waldschmidt. 1995. Murine B-cell subsets defined by CD23. Methods Companion Methods Enzymol. 8:3.
54. Erickson, L. D., L. T. Tygrett, S. K. Bhatia, K. H. Grabstein, and T. J. Waldschmidt. 1996. Differential expression of CD22 (Lyb8) on murine B cells. Int. Immunol. 8:1121.
55. Allman, D., S. E. Ferguson, V. M. Lentz, and M. P. Cancro. 1993. Peripheral B cell maturation: heat-stable antigen-hi splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151:4431.
56. Li, B., C. Sallee, M. Dehoff, S. Foley, H. Molina, and V. M. Holers. 1993. Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151:4295.
57. Molina, H., T. Kinoshita, C. B. Webster, and V. M. Holers. 1994. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153:789.
58. Reap, E. A., M. L. Piecyk, A. Oliver, E. S. Sobel, T. Waldschmidt, P. L. Cohen, and R. A. Eisenberg. 1996. Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin. Exp. Immunopathol. 78:21.
59. Hartley, S. B., M. P. Cooke, D. A. Fulcher, A. W. Harris, S. Cory, A. Basten, and C. C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325.
60. Cyster, J. G., and C. C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2:13.
61. Llopsis, M.-J., G. Harms, M. J. Hardonk, and W. Timens. 1996. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J. Allergy Clin. Immunol. 97:1015.
62. Tedder, T. F., L.-J. Zhou, and P. Engel. 1994. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15:437.
63. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127.
64. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:55.
65. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149: 2841.
66. Krop, I., L. A. Shaffer, T. D. Fearon, and S. M. Schlissel. 1996. The signaling activity of murine CD19 is regulated during B cell development. J. Immunol. 157:48.
67. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
68. Morris, D. L., and T. L. Rothstein. 1995. Analysis of B-1 cell activation. Methods: Companion Methods Enzymol. 8:11.
69. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352.
70. Tarakhovsky, A., M. Turner, S. Schaal, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. J. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467.
71. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1996. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470.
72. Weng, W. K., L. Jarvis, and T. W. LeBien. 1994. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269:32514.
73. Krop, I., A. R. de Fougerolles, R. R. Hardy, M. Allison, M. S. Schlissel, and D. T. Fearon. 1996. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:238.
74. Edberg, J. C., L. Tosic, and R. P. Taylor. 1989. Immune adherence and the processing of soluble complement-fixing antibody/DNA immune complexes in mice. Clin. Immunol. Immunopathol. 51:118.
75. Granholm, N. A., and T. Cavallo. 1990. Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice. Clin. Exp. Immunol. 82:300.
76. Meryhew, N. L., and R. P. Messner. 1993. Murine complement-mediated immune clearance dysfunction is associated with the lymphoproliferative (lpr) gene. Clin. Immunol. Immunopathol. 69:324.
77. 1 mice. Scand. J. Immunol. 42:466.
78. Heyman, B., S. Gustavsson, C. Kusakari, M. Nose, T. Kinoshita, L. Klareskog, and A. Tarkowski. 1993. Antibody feedback regulation in MRL/lpr mice. J. Autoimmun. 6:437.
79. Cosio, F. G., D. D. Sedmak, J. D. Mahan, and N. S. Nahman. 1989. Localization of decay-accelerating factor in normal and diseased kidneys. Kidney Int. 36:100.
80. Endoh, M., M. Yamashina, H. Oh, K. Funahashi, T. Ikuno, T. Yasugi, J. P. Atkinson, and H. Okada. 1993. Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues. Clin. Exp. Immunol. 94:182.
81. Ma, J., J. Xu, P. M. Madaio, Q. Peng, J. Zhang, S. I. Grewal, A. R. Flavell, and J. Craft. 1996. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J. Immunol. 157: 417.